title: Evaluation of lung cancer by 99mTc-tetrofosmin SPECT: comparison with [18F]FDG-PET.
abstract: OBJECTIVE
  The purpose of this study was to clarify the validity of (99m)Tc-tetrofosmin SPECT (TF-SPECT) in the evaluation of lung cancer in comparison with [18F]fluorodeoxyglucose ([18F]FDG-PET).
  
  
  METHODS
  Twenty-one patients with biopsy-proven non-small cell lung cancer were examined by both TF-SPECT (early and delayed images) and FDG-PET within a week of each study. Lung cancers were analyzed visually and semiquantitatively using the ratio of lesion to background counts (L/B ratio). Mediastinal lymph node metastases were analyzed only visually.
  
  
  RESULTS
  Both early and delayed TF images could detect 18 of 21 lung cancers on visual analysis (85.7%), whereas FDG-PET could detect all the lesions (100%). The L/B ratio of TF-SPECT was significantly higher in delayed than in early images (1.79 +/- 0.55 vs. 1.56 +/- 0.40; p < 0.001). However, the L/B ratio of FDG-PET was 8.85 +/- 3.05, significantly higher than those of both TF images (p < 0.0001). In the assessment of mediastinal involvement, TF-SPECT was 40.0% sensitive, 100% specific, and 71.4% accurate, whereas FDG-PET was 80.0% sensitive, 81.8% specific, and 81.0% accurate.
  
  
  CONCLUSIONS
  Although the detection sensitivity was far better than expected, TF-SPECT is not considered to be an alternative to FDG-PET in the evaluation of malignant pulmonary lesions because of its significantly low L/B ratio. TF-SPECT has poor sensitivity for mediastinal lymph node metastases and is useless for staging patients with lung cancer.
authors.affiliation: Division of Tracer Kinetics, Biomedical Research Center, Osaka University Graduate School of Medicine, Japan. tatsumi@tracer.med.osaka-u.ac.jp
authors.forename: M
authors.initials: M
authors.lastname: Tatsumi
authors.forename: K
authors.initials: K
authors.lastname: Yutani
authors.forename: T
authors.initials: T
authors.lastname: Nishimura
mesh_terms: D005069:Evaluation Studies as Topic; D005260:Female; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18 / Q000378:metabolism; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging; D008297:Male; D008479:Mediastinal Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary; D008875:Middle Aged; D009943:Organophosphorus Compounds / Q000378:metabolism; D015609:Organotechnetium Compounds / Q000378:metabolism; D011786:Quality Control; D014055:Tomography, Emission-Computed; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D005462:Fluorine Radioisotopes; D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D019788:Fluorodeoxyglucose F18; C078700:technetium tc-99m tetrofosmin